Long-Term Efficacy and Safety Among Patients With Severe Eosinophilic Asthma Treated With Mepolizumab and Its Effect on Small Airways.

Strauss, Ronald; Leflein, Hannah; Kolesar, Anna; Hammel, Jeffrey

Strauss, Ronald; Leflein, Hannah; Kolesar, Anna; Hammel, Jeffrey.

Afiliación

Strauss R; Cleveland Allergy and Asthma Center and Case Western Reserve University School of Medicine, Cleveland, Ohio. Electronic address: straussallergy@yahoo.com.
Leflein H; Case Western Reserve University, Cleveland Allergy and Asthma Center, Cleveland, Ohio.
Kolesar A; Case Western Reserve University, Cleveland Allergy and Asthma Center, Cleveland, Ohio.
Hammel J; Case Western Reserve University, Cleveland Allergy and Asthma Center, Cleveland, Ohio.

J Allergy Clin Immunol Pract ; 11(12): 3670-3679.e2, 2023 12.

Article en En | MEDLINE | ID: mdl-37572752

Asunto(s)

Antiasmáticos; Asma; Eosinofilia Pulmonar; Humanos; Anticuerpos Monoclonales Humanizados/efectos adversos; Eosinofilia Pulmonar/tratamiento farmacológico; Volumen Espiratorio Forzado; Resultado del Tratamiento

Palabras clave

ACQ-6; ACQ-7; Asthma; Eosinophilic asthma; Eosinophils; FEF25%75%; FEV1; Mepolizumab; Pulmonary function tests; Small airway disease; Super-responders; Wilcoxon signed rank test

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Eosinofilia Pulmonar / Asma / Antiasmáticos Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google